OBI Pharma is a biopharmaceutical company that engages in researching and developing drugs for cancer and infectious diseases. OBI Pharma was founded in 2002. OBI Pharma's headquarters is located in Taipei, Taipei (municipality), TW 11503.
OBI Pharma's Co-Founder, Michael Chang, currently has an approval
rating of 70%. OBI Pharma's primary competitors are
There are no competitors identified for OBI Pharma
There have been no acquisitions found related to OBI Pharma
Funding data cannot be found related to OBI Pharma
Recent investment data cannot be found related to OBI Pharma